⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEVA News
Teva Pharmaceutical Industries Limited American Depositary Shares
Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®
globenewswire.com
ALVO
TEVA
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
globenewswire.com
ALVO
TEVA
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
globenewswire.com
ALVO
TEVA
Teva to Present at the Goldman Sachs Global Healthcare Conference
globenewswire.com
TEVA
Form 8-K
sec.gov
TEVA
TEVJF
Interact Enters a New Era of Growth with Brand Evolution, AI Innovation, and Industry Recognition
globenewswire.com
LEVI
DPZ
TEVA
Medincell to Participate in Jefferies and Evercore Investor Conferences in the U.S. in June
businesswire.com
TEVA
CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies - Persistence Market Research
prnewswire.com
AMGN
LLY
TEVA
PFE
ABBV
The European Medicines Agency Accepts Teva’s Marketing Authorization Application for Olanzapine Long-Acting Injectable (TEV-‘749) for the Treatment of Schizophrenia in Adults
globenewswire.com
TEVA
Interact Advances its Agentic AI Vision with Content Moderation, Cross-System Search, and Workday Workflows
globenewswire.com
DPZ
TEVA